These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis. Park MJ, Kim YK, Lee MH, Lee JH. Acta Radiol; 2013 Mar 01; 54(2):127-36. PubMed ID: 23148300 [Abstract] [Full Text] [Related]
7. Hepatocellular nodules in liver cirrhosis: contrast-enhanced MR. Bartolozzi C, Battaglia V, Bozzi E. Abdom Imaging; 2011 Jun 01; 36(3):290-9. PubMed ID: 21267561 [Abstract] [Full Text] [Related]
8. CT and MRI of hepatocellular carcinoma: an update. Ayyappan AP, Jhaveri KS. Expert Rev Anticancer Ther; 2010 Apr 01; 10(4):507-19. PubMed ID: 20397916 [Abstract] [Full Text] [Related]
9. Cirrhosis: spectrum of findings on unenhanced and dynamic gadolinium-enhanced MR imaging. Vitellas KM, Tzalonikou MT, Bennett WF, Vaswani KK, Bova JG. Abdom Imaging; 2001 Apr 01; 26(6):601-15. PubMed ID: 11907725 [Abstract] [Full Text] [Related]
10. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Willatt JM, Hussain HK, Adusumilli S, Marrero JA. Radiology; 2008 May 01; 247(2):311-30. PubMed ID: 18430871 [Abstract] [Full Text] [Related]
11. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Kim JI, Lee JM, Choi JY, Kim YK, Kim SH, Lee JY, Han JK, Choi BI. Invest Radiol; 2008 Mar 01; 43(3):202-10. PubMed ID: 18301317 [Abstract] [Full Text] [Related]
12. Hepatocellular carcinoma: development and early detection. Robinson P. Cancer Imaging; 2008 Oct 04; 8 Spec No A(Spec Iss A):S128-31. PubMed ID: 18852086 [Abstract] [Full Text] [Related]
13. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis. Kim YK, Lee YH, Kwak HS, Kim CS, Han YM. Clin Imaging; 2008 Oct 04; 32(6):453-9. PubMed ID: 19006774 [Abstract] [Full Text] [Related]
14. [Comparative evaluation of echography, computerized tomography and magnetic resonance imaging in the diagnosis of hepatocellular carcinoma in cirrhotic patients]. Dalla Palma L, Pozzi-Mucelli RS, Bazzocchi M, Pozzi-Mucelli R, Ferrara P. Radiol Med; 1991 Oct 04; 81(1-2):8-15. PubMed ID: 1848720 [Abstract] [Full Text] [Related]
15. Stepwise carcinogenesis of hepatocellular carcinoma in the cirrhotic liver: demonstration on serial MR imaging. van den Bos IC, Hussain SM, Terkivatan T, Zondervan PE, de Man RA. J Magn Reson Imaging; 2006 Nov 04; 24(5):1071-80. PubMed ID: 17024654 [Abstract] [Full Text] [Related]
16. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver. Le Moigne F, Durieux M, Bancel B, Boublay N, Boussel L, Ducerf C, Berthezène Y, Rode A. Magn Reson Imaging; 2012 Jun 04; 30(5):656-65. PubMed ID: 22459435 [Abstract] [Full Text] [Related]
17. MR imaging of hepatocellular carcinoma. Onaya H, Itai Y. Magn Reson Imaging Clin N Am; 2000 Nov 04; 8(4):757-68. PubMed ID: 11149678 [Abstract] [Full Text] [Related]
19. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls of cirrhosis-related nodules. Jeong YY, Yim NY, Kang HK. AJR Am J Roentgenol; 2005 Oct 04; 185(4):1024-32. PubMed ID: 16177427 [Abstract] [Full Text] [Related]
20. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging. Yu JS, Lee JH, Chung JJ, Kim JH, Kim KW. Acta Radiol; 2008 Sep 04; 49(7):735-43. PubMed ID: 18608015 [Abstract] [Full Text] [Related] Page: [Next] [New Search]